[ Price : $8.95]
FDA announces a 5/18 virtual public workshop aimed at advancing the use of novel surrogate endpoints in developing treatments for ...[ Price : $8.95]
Insmed discontinues development of its drug candidate brensocatib for hidradenitis suppurativa after a mid-stage clinical trial fa...[ Price : $8.95]
Baker Hostetler attorney Winston Kirton says life sciences companies that are active in both the U.S. and the EU need to change th...[ Price : $8.95]
A Clinical Trial Vanguard online column explains how a 2022 FDA master protocol guidance has not kept pace with non-oncology baske...[ Price : $8.95]
FDA removes partial clinical hold against MacroGenics Phase 2 LINNET study evaluating the investigational cancer therapy lorigerli...[ Price : $8.95]
An FDA Matters column calls on FDA to fully enforce the laws against mass compounding of approved drugs that are not in shortage.[ Price : $8.95]
FDA warns Newport Beach, CA-based physician Ehsan Sadri about failing to follow the investigational plan in two clinical trials.[ Price : $8.95]
FDA plans a two-day public workshop next month aimed at improving how pregnancy registries are designed and used to assess the saf...